Atricure to participate in the 43rd annual j.p. morgan healthcare conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in the upcoming 43rd annual j.p. morgan healthcare conference. atricure's management is scheduled to present on wednesday, january 15, 2025, at 3:00 pm pacific standard time. interested parties may access a live audio.
ATRC Ratings Summary
ATRC Quant Ranking